Clinical and Regulatory committee
The Clinical and Regulatory Committee is appointed within the Board and deals with issues regarding the Company’s clinical development plan and clinical trials for arfolitixorin as well as regulatory issues with authorities.
The committee consists of Ulf Jungnelius, Chairman of the Committee, Alain Herrera and Bengt Gustavsson. Sten Nilsson is adjunct to the committee.
The committee has the following main areas of responsibility: